In a 6-week human study, Vitaloss
almost tripled weight loss compared to diet and exercise alone (11.77 pounds versus 4.40 pounds). It was established that 88% of the subjects on Vitaloss
experienced marked appetite suppression and 92% of the weight loss was fat, not water.
was studied in a prospective, double-blind, randomized, placebo-controlled human clinical trial performed by independent third party investigators who specialize in the supervision of this type of human experimentation. The study was conducted under the direction of an Institutional Review Board (IRB) that assures volunteers are safely treated. The test results were then published in a peer-reviewed medical journal.
The link to the Vitaloss
published paper can be found: Here
- Patent (US 6,579,866)
Composition and Method for Modulating Nutrient Partitioning
patent covers a very unique nutritional formulation that is designed to promote weight loss and improve metabolic health.
It does so by modifying the related processes of fat and glucose (sugar) metabolism. This is accomplished by combining nutrients that enhance fat oxidation (fat burning) and glucose storage - a state that is associated with lower body mass.
These changes are associated with diminished appetite and improvement in the physiologic components of the Metabolic Syndrome (blood pressure, obesity, glucose and insulin regulation, and lipoprotein metabolism). The mechanism of action involves up-regulation of futile carbohydrate cycles in the liver.